VEGFB Antikörper
Kurzübersicht für VEGFB Antikörper (ABIN736313)
Target
Alle VEGFB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human VEGFB
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:100-1000
IHC-P 1:100-500
IF(IHC-P) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C
-
Haltbarkeit
- 12 months
-
-
- VEGFB (Vascular Endothelial Growth Factor B (VEGFB))
-
Andere Bezeichnung
- Vegf-B
-
Hintergrund
-
Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis.
Subcellular location: Secreted
Synonyms: VRF, VEGFL, Vascular endothelial growth factor B, VEGF-B, VEGF-related factor, VEGFB
-
Gen-ID
- 7423
-
UniProt
- P49765
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Target
-